Evidence map›Paper›PMID 35941129›Full record

ArticleTranslational psychiatry2022

Identification of activity-induced Egr3-dependent genes reveals genes associated with DNA damage response and schizophrenia.

Ketan K Marballi, Khaled Alganem, Samuel J Brunwasser, Arhem Barkatullah, Kimberly T Meyers, Janet M Campbell, Annika B Ozols, Robert E Mccullumsmith, Amelia L Gallitano

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. PGx-BasedCurrent neuropharmacology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. A Comprehensive 4-layeredCurrent pharmaceutical biotechnology · 2025
    Article
  11. Current neuropharmacology · 2025
    Article
  12. Analysis of the underlying mechanism ofPharmaceutical science advances · 2024
    Article
  13. Article
  14. Article
  15. Science advances · 2024
    Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Ketan K MarballiDepartment of Basic Medical Sciences, University of Arizona College of Medicine - Phoenix, Phoenix, AZ, 85004, USA.
Khaled AlganemDepartment of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA.
Samuel J BrunwasserWashington University, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Arhem BarkatullahDepartment of Basic Medical Sciences, University of Arizona College of Medicine - Phoenix, Phoenix, AZ, 85004, USA.
Kimberly T MeyersDepartment of Basic Medical Sciences, University of Arizona College of Medicine - Phoenix, Phoenix, AZ, 85004, USA.
Janet M CampbellDepartment of Basic Medical Sciences, University of Arizona College of Medicine - Phoenix, Phoenix, AZ, 85004, USA.
Annika B OzolsDepartment of Basic Medical Sciences, University of Arizona College of Medicine - Phoenix, Phoenix, AZ, 85004, USA.ORCID 0000-0001-6760-4931
Robert E MccullumsmithDepartment of Neurosciences, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA.ORCID 0000-0001-6921-7150
Amelia L GallitanoDepartment of Basic Medical Sciences, University of Arizona College of Medicine - Phoenix, Phoenix, AZ, 85004, USA. amelia@arizona.edu.ORCID 0000-0002-0544-7114
University of Arizona · USBarrow Neurological Institute · USNeurosciences Institute · USUniversity of Toledo · USWashington University in St. Louis · US

Funding

Translational assessment of brain bioenergetic function in schizophreniaR01MH121102 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI MARANO, CHRISTOPHER, MCCULLUMSMITH, ROBERT E · 2020 to 2024
$3.7M
Mechanism of 5HT2AR regulation by Egr3R01MH097803 · NIMH · UNIVERSITY OF ARIZONA · PI GALLITANO, AMELIA · 2012 to 2023
$3.5M
Development of Attenuated Furoxans as Novel Therapies for Alzheimer's DiseaseR01AG057598 · NIA · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI SCHIEFER, ISAAC T · 2018 to 2022
$2.3M
Cell-specific analysis of sub-kinomes in schizophreniaR01MH107487 · NIMH · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI MCCULLUMSMITH, ROBERT E, MELLER, JAREK · 2016 to 2020
$1.9M
Molecular mechanisms underlying the therapeutic effect of ECTR21MH113154 · NIMH · UNIVERSITY OF ARIZONA · PI GALLITANO, AMELIA · 2018 to 2019
$398k
NIA NIH HHS R01 AG057598NIA NIH HHS R01AG057598NIMH NIH HHS R01 MH097803NIMH NIH HHS R01MH097803NIMH NIH HHS R01 MH107487NIMH NIH HHS R01MH107487NIMH NIH HHS R01 MH121102NIMH NIH HHS R01MH121102NIMH NIH HHS R21 MH113154NIMH NIH HHS R21MH113154
6 · The paper itself

Abstract

Bioinformatics and network studies have identified the immediate early gene transcription factor early growth response 3 (EGR3) as a master regulator of genes differentially expressed in the brains of patients with neuropsychiatric illnesses ranging from schizophrenia and bipolar disorder to Alzheimer's disease. However, few studies have identified and validated Egr3-dependent genes in the mammalian brain. We have previously shown that Egr3 is required for stress-responsive behavior, memory, and hippocampal long-term depression in mice. To identify Egr3-dependent genes that may regulate these processes, we conducted an expression microarray on hippocampi from wildtype (WT) and Egr3-/- mice following electroconvulsive seizure (ECS), a stimulus that induces maximal expression of immediate early genes including Egr3. We identified 69 genes that were differentially expressed between WT and Egr3-/- mice one hour following ECS. Bioinformatic analyses showed that many of these are altered in, or associated with, schizophrenia, including Mef2c and Calb2. Enrichr pathway analysis revealed the GADD45 (growth arrest and DNA-damage-inducible) family (Gadd45b, Gadd45g) as a leading group of differentially expressed genes. Together with differentially expressed genes in the AP-1 transcription factor family genes (Fos, Fosb), and the centromere organization protein Cenpa, these results revealed that Egr3 is required for activity-dependent expression of genes involved in the DNA damage response. Our findings show that EGR3 is critical for the expression of genes that are mis-expressed in schizophrenia and reveal a novel requirement for EGR3 in the expression of genes involved in activity-induced DNA damage response.

Indexed as

Bipolar DisorderSchizophreniaAnimalsAntigens, DifferentiationDNA DamageEarly Growth Response Protein 3GADD45 ProteinsMammalsMiceTranscription FactorsAntigens, DifferentiationEarly Growth Response Protein 3Egr3 protein, mouseGadd45b protein, mouseGADD45 ProteinsTranscription Factors

Identifiers

PMID35941129
PMCPMC9360026
OpenAlexW4290699994

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.